Cystatin C as a Marker of Progressing Cardiovascular Events during Coronary Heart Disease


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The role of cystatin C, an inhibitor of cysteine proteases, as an alternative and potent predictor of acute cardiovascular events in coronary heart disease (CHD) patients was examined and compared to that of other markers of cardiorenal abnormalities. The patients with CHD demonstrated elevated serum cystatin C, especially in cases with serious risk of cardiovascular complications. In comparison with other indicators of cardiorenal dysfunction, cystatin C can be viewed as an alternative predictor of cardiovascular complications, although its sensitivity is inferior to that of high-sensitivity C-reactive protein and natriuretic peptide.

作者简介

M. Gevorgyan

Research Institute of Physiology and Fundamental Medicine

Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk

N. Voronina

Research Institute of Biochemistry

Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk

N. Goncharova

Research Institute of Physiology and Fundamental Medicine

Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk

T. Kozaruk

Research Institute of Biochemistry

Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk

G. Russkikh

Research Institute of Physiology and Fundamental Medicine

Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk

L. Bogdanova

Research Institute of Molecular Pathology and Pathomorphology

Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk

T. Korolenko

Research Institute of Physiology and Fundamental Medicine

编辑信件的主要联系方式.
Email: t.a.korolenko@physiol.ru
俄罗斯联邦, Novosibirsk


版权所有 © Springer Science+Business Media New York, 2017
##common.cookie##